b-Arrestins in the Central Nervous System - Progress in Molecular Biology and Translational Science - page 286

151. Drake MT, Shenoy SK, Lefkowitz RJ. Trafficking of G protein-coupled receptors. Circ
Res . 2006;99(6):570- 582.
152. Holmes KD, Babwah AV, Dale LB, Poulter MO, Ferguson SS. Differential regulation
of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-
arrestins and Rab GTPases. J Neurochem . 2006;96(4):934 - 949.
153. Oakley RH, Olivares-Reyes JA, Hudson CC, Flores-Vega F, Dautzenberg FM,
Hauger RL. Carboxyl-terminal and intracellular loop sites for CRF1 receptor phos-
phorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety
responses. Am J Physiol Regul Integr Comp Physiol . 2007;293(1):R209- R222.
154. Markovic D, Punn A, Lehnert H, Grammatopoulos DK. Intracellular mechanisms reg-
ulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction
with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase sig-
naling cascades. Mol Endocrinol . 2008;22(3):689- 706.
155. Gutknecht E, Hauger RL, Van der Linden I, Vauquelin G, Dautzenberg FM. Expres-
sion, binding, and signaling properties of CRF2(a) receptors endogenously expressed in
human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors.
J Neurochem . 2008;104(4):926- 936.
156. Breivogel CS, Lambert JM, Gerfin S, Huffman JW, Razdan RK. Sensitivity to delta9-
tetrahydrocannabinol is selectively enhanced in beta-arrestin2 / mice. Behav

Pharmacol . 2008;19(4):298- 307.
157. Arlinde C, Sommer W, Bjork K, et al. A cluster of differentially expressed signal trans-
duction genes identified by microarray analysis in a rat genetic model of alcoholism.
Pharmacogenomics J . 2004;4(3):208 - 218.
158. Sommer W, Hyytia P, Kiianmaa K. The alcohol-preferring AA and alcohol-avoiding
ANA rats: neurobiology of the regulation of alcohol drinking. Addict Biol . 2006;11
(3- 4):289- 309.
159. Bjork K, Rimondini R, Hansson AC, et al. Modulation of voluntary ethanol consump-
tion by beta-arrestin 2. FASEB J . 2008;22(7):2552- 2560.
160. Schreiber G, Golan M, Avissar S. Beta-arrestin signaling complex as a target for anti-
depressants and as a depression marker. Drug News Perspect . 2009;22(8):467- 480.
161. Allen JA, Yost JM, Setola V, et al. Discovery of beta-arrestin-biased dopamine D2
ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc
Natl Acad Sci USA . 2011;108(45):18488- 18493.
162. Rozenfeld R, Devi LA. Exploring a role for heteromerization in GPCR signalling
specificity. Biochem J . 2011;433(1):11 - 18.
163. Swift JL, Godin AG, Dore K, et al. Quantification of receptor tyrosine kinase trans-
activation through direct dimerization and surface density measurements in single cells.
Proc Natl Acad Sci USA . 2011;108(17):7016 - 7021.
164. Oligny-Longpre G, Corbani M, Zhou J, Hogue M, Guillon G, Bouvier M. Engage-
ment of beta-arrestin by transactivated insulin-like growth factor receptor is needed for
V2 vasopressin receptor-stimulated ERK1/2 activation. Proc Natl Acad Sci USA .
2012;109(17):E1028 - E1037.